Koyfin Home > Directory > Health Care > Amphastar Pharma > EV / EBITDA (ntm)

Amphastar Pharma EV / EBITDA (ntm) Chart (AMPH)

Amphastar Pharma annual/quarterly EV / EBITDA (ntm) from 2014 to 2018. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Amphastar Pharma EV / EBITDA (ntm) for the quarter ending March 03, 2018 was 16.73 a 2.56% increase of 0.43 year over year
  • Amphastar Pharma Annual EV / EBITDA (ntm) for 2017 was 17.06 a -29.70% decrease of -5.07 from 2016
  • Amphastar Pharma Annual EV / EBITDA (ntm) for 2016 was 22.12 a -301.65% decrease of -66.74 from 2015
  • Amphastar Pharma Annual EV / EBITDA (ntm) for 2014 was 88.86
Other Valuation Metrics:
  • Amphastar Pharma Market Cap for the quarter ending March 03, 2018 was $869m a 6.01% increase of 52m year over year
  • Amphastar Pharma Price / Book for the quarter ending March 03, 2018 was 2.59 a 2.71% increase of 0.07 year over year
  • Amphastar Pharma Enterprise Value for the quarter ending March 03, 2018 was $848m a 8.52% increase of 72m year over year
View Chart On Koyfin

Quarterly AMPH EV / EBITDA (ntm) Data

03/201816.73
12/201717.06
09/201717.66
06/201716.30
03/201714.63
12/201622.12
09/201632.25
06/201628.80
03/2015107.09
12/201488.86

Annual AMPH EV / EBITDA (ntm) Data

201717.06
201622.12
201488.86